We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 16.00 | 15.50 | 16.50 | 16.00 | 16.00 | 16.00 | 38,250 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 5.63 | 14.59M |
Date | Subject | Author | Discuss |
---|---|---|---|
04/8/2018 14:58 | I'm pretty sure I have that too!! Ha ha | robo28 | |
04/8/2018 14:55 | Have just reread the second part of elric interview with soh. Some VERY VERY strong hints about lpldl pharma tie up and valuations. Also expecting huge surprise news from Tata over coming months that again will exponentially effect valuation? Strong words for an historically cautious man. S | shrewdmole | |
04/8/2018 14:46 | I've been to the doctors, and they've finally diagnosed me with COD. Turns out it's Compulsive Opti Disorder, based on the fact that I check this thread 20x a day! John | 2350220 | |
04/8/2018 13:34 | Monkey, what do you feel is the right price for Opti right now? | loungeact | |
04/8/2018 13:21 | I think we will need all the rampers efforts to keep the share price this high. | monkeywench1 | |
04/8/2018 13:20 | Oh dear rampyslartfartfaster has been owned by the mouse!! Lmao. | monkeywench1 | |
04/8/2018 12:01 | Fantastic post and response Risky! | malreid | |
04/8/2018 10:46 | Let's ride the light fantastic .... 2 items of outrageously good news and a serious insti buys in ....... ooooh errrr missus | ramas | |
04/8/2018 10:25 | Asat - I think you make some valid points about scientific research in general (eg sample sizes, experimental design and length of trials). However, the example below, which was part of an RNS in January, shows what seems acceptable when testing more general consumer food products. Rather than the more stringent needs for pharmaceuticals. I say that based on my limited (and now somewhat distant) knowledge of statistics. What do you (and others) think? "This announcement reports on human taste studies carried out on OptiBiotix's sweet healthy natural fibres compared to existing sugars and prebiotics. The studies were performed by The Flavour and Sensory Science Centre at the University of Reading and tested eight samples (including OptiBiotix's test sample) using an expert panel of 11 experienced panellists who rated 11 attributes compared to sucrose. The tests showed:- Of the 11 attributes rated, eight were significantly different between samples. The most substantial differences were in sweet taste, strength of off-flavour and sweet after taste. The sweet oligosaccharide developed by OptiBiotix was significantly sweeter than all other samples and low in all off-flavours (e.g. bitterness, sourness, staleness, saltiness etc). The results of this independent study provide proof of product concept for natural, low calorie, sweet healthy fibres with gut microbiome functionality as potential bulk sugar replacement in a wide range of food products." | m4rtinu | |
04/8/2018 08:37 | asat91 re Immupharma phase 3, I think the late inclusion of Mauritius into the trial also threw the result with the crucial placebo effect, and there should have been more people in the trial. The 7% full remission shows it has some value still. What the management do with that will show their true value, and with the chairman owning so much, I don't think they will let it go easily. | dontshoutatonce | |
04/8/2018 08:29 | Thanks for posting that Judijudi. The Daily Mail, for all its faults, does seem to have quite a Theme going on with Microbiome stories. I think that this, and the many other articles they've done, Must be paving the way to making the whole idea of solving medical issues through the Microbiome, much more mainstream. Which, ultimately, must be positive for us, if our folks can put their PR hats on. John | 2350220 | |
04/8/2018 08:11 | robo, Yes. I believe so It’s just one of the potentially massive products that Mr OH has up his sleeve | judijudi | |
04/8/2018 08:05 | Very interesting judi, haven't we already identified the bacteria the article is talking about and have a product soon out for mental health and depression ?? Ahead of the game again if we have , when I say we I mean Opti ! really feel apart of it now ha ha ha | robo28 | |
04/8/2018 07:16 | Great post risky | judijudi | |
03/8/2018 23:25 | and TWs clock is finally called time correctly. I see hear he is saying next week will be a 'good week' for Opti. I assume he is expecting a juicy news item. | slartybartfaster | |
03/8/2018 23:12 | “That F19 jet on steroids has now taken off” - yeah baby. Although, I feel like SOH has built the F19 and only just started the engine. Engine sounds good. | polus | |
03/8/2018 22:46 | I still think Slimbiome is the weak link. Happy to be proved wrong but Tata are taking a long time. Hmmm. | monkeywench1 | |
03/8/2018 22:23 | I agree! Risky as ever I am in awe! Never cease to impress. Cheers! Bernie | bernieboy | |
03/8/2018 22:22 | I don't think anyone said opti would be self funding at this stage, you made that up. I'm sure if this was the case you would copy paste the post wouldn't you, michelle. Breakeven year calendar year end was suggested, that's not the same is it. Always twisting the facts. | slartybartfaster | |
03/8/2018 22:20 | Risky, that is some post. Wow the science explained so well. | rafboy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions